MicroRNA Regulation of Osteogenic Differentiation in Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) possess the intrinsic capacity to differentiate into osteoblasts, chondrocytes and adipocytes, making them central to bone repair and tissue engineering. MicroRNAs are ~22-nucleotide non-coding RNAs that fine-tune gene expression by binding to the 3′ untranslated region of messenger RNAs, leading to transcript degradation or translational repression. During osteogenic differentiation, specific microRNAs act either as promoters—by down-regulating inhibitors of bone formation such as phosphatases or extracellular matrix repressors—or as suppressors, targeting osteogenic transcription factors and signalling mediators. Key pathways modulated include Wnt/β-catenin, BMP/Smad and PI3K/Akt, with emerging evidence of feedback loops in which RUNX2 and other transcription factors regulate microRNA transcription to reinforce lineage commitment. Precise temporal control of these small RNAs ensures orderly matrix deposition and mineralisation. Dysregulation of microRNA networks has been linked to osteoporosis, impaired fracture healing and ectopic bone formation, underscoring their potential as biomarkers and therapeutic targets. Advances in delivery technologies—ranging from lipid nanoparticles to scaffold-based release systems—offer promising routes to harness microRNA modulation for bone regeneration, bridging basic biology and clinical application.

Research from Nature Portfolio

No recent Nature Portfolio content available.

MicroRNA Regulation of Osteogenic Differentiation in Mesenchymal Stem Cells publication trend

The graph below shows the total number of articles in microrna regulation of osteogenic differentiation in mesenchymal stem cells across all publications each year (not limited to Nature Index journals).

Technical terms

MicroRNA (miRNA): Small non-coding RNA of ~22 nucleotides that regulates gene expression by binding to the 3′ untranslated region of target mRNAs, inducing degradation or translational repression.

Mesenchymal stem cell (MSC): Multipotent stromal cell capable of self-renewal and differentiation into osteoblasts, chondrocytes and adipocytes, found in bone marrow and various tissues.

Osteogenic differentiation: Process by which MSCs commit to and mature into osteoblasts, involving sequential activation of transcription factors and extracellular matrix mineralisation.

3′ untranslated region (3′ UTR): Non-coding segment at the end of an mRNA molecule that contains regulatory elements for post-transcriptional control.

RUNX2: Master transcription factor essential for initiation of osteoblast differentiation and regulation of bone-related genes.

Bone morphogenetic protein (BMP): Family of growth factors in the TGF-β superfamily that promote osteogenesis through Smad-dependent signalling.

References

1. Mir155 regulates osteogenesis and bone mass phenotype via targeting S1pr1 gene. eLife (2023).
2. MiR-199a-5P promotes osteogenic differentiation of human stem cells from apical papilla via targeting IFIT2 in apical periodontitis. Frontiers in Immunology (2023).
3. Unveiling Mesenchymal Stem Cells’ Regenerative Potential in Clinical Applications: Insights in miRNA and lncRNA Implications. Cells (2023).